We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $688M
1-Year Est. Return 63.4%
This Fund
S&P 500
This Quarter Est. Return
+23.71%
1 Year Est. Return
+63.4%
3 Year Est. Return
+248.3%
5 Year Est. Return
+571.65%
10 Year Est. Return
+5,300.27%
AUM
$642M
AUM Growth
+$86.9M
Cap. Flow
+$11M
Cap. Flow %
1.72%
Top 10 Hldgs %
35.11%
Holding
408
New
173
Increased
29
Reduced
65
Closed
84

Sector Composition

Rank Sector Weight
1 Financials 22.59%
2 Technology 9.79%
3 Consumer Discretionary 7.01%
4 Industrials 6.44%
5 Healthcare 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENR icon
226
Energizer
ENR
$1.54B
$255K 0.04%
6,050
-3,450
-36% -$146K
CVS icon
227
CVS Health
CVS
$121B
$249K 0.04%
3,650
+150
+4% +$9.76K
HCA icon
228
HCA Healthcare
HCA
$89B
$247K 0.04%
1,500
-1,000
-40% -$146K
BDX icon
229
Becton Dickinson
BDX
$49.6B
$245K 0.04%
1,005
+31
+3% +$7.23K
MRK icon
230
Merck
MRK
$332B
$241K 0.04%
3,085
+360
+13% +$27.5K
BG icon
231
Bunge Global
BG
$21.7B
$236K 0.04%
3,600
-2,300
-39% -$134K
LATNW
232
DELISTED
Union Acquisition Corp. II Warrant
LATNW
$235K 0.04%
246,900
BC icon
233
Brunswick
BC
$5.3B
$229K 0.04%
3,000
-400
-12% -$28.2K
PARA
234
DELISTED
Paramount Global Class B
PARA
$229K 0.04%
+6,150
New +$197K
MRACU
235
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
$219K 0.03%
+20,200
New +$216K
DISH
236
DELISTED
DISH Network Corp.
DISH
$217K 0.03%
6,700
-2,000
-23% -$61.5K
MNR
237
DELISTED
Monmouth Real Estate Investment Corp
MNR
$217K 0.03%
+12,500
New +$189K
MSPRZ
238
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$208K 0.03%
+178,050
New +$162K
SBGI icon
239
Sinclair Inc
SBGI
$1.02B
$207K 0.03%
+6,500
New +$155K
PFPT
240
DELISTED
Proofpoint, Inc.
PFPT
$205K 0.03%
+1,500
New +$164K
AB icon
241
AllianceBernstein
AB
$3.41B
$203K 0.03%
+6,000
New +$190K
KPLTW
242
DELISTED
Katapult Holdings Warrant
KPLTW
$202K 0.03%
57,750
-35,400
-38% -$53.8K
PRGO icon
243
Perrigo
PRGO
$1.76B
$201K 0.03%
4,500
ORGNW
244
DELISTED
Origin Materials Inc Warrants
ORGNW
$196K 0.03%
88,969
SSP icon
245
E.W. Scripps
SSP
$310M
$191K 0.03%
12,500
-1,900
-13% -$23.4K
SNAXW
246
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$173K 0.03%
216,100
-9,700
-4% -$3.44K
CANO
247
DELISTED
Cano Health, Inc.
CANO
$170K 0.03%
127
-2,254
-95% -$2.58M
XL.WS
248
DELISTED
XL Fleet Corp. Redeemable Warrants, each whole warrant exercisable for shares of Class A common stoc
XL.WS
$168K 0.03%
+20,764
New +$173K
HBP
249
DELISTED
Huttig Building Products, Inc.
HBP
$163K 0.03%
+44,452
New +$150K
EVH icon
250
Evolent Health
EVH
$516M
$160K 0.02%
10,000

Similar funds

Gabelli & Co Investment Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Gabelli & Co Investment Advisers held 408 positions worth $642M, up 16% from $555M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Gabelli & Co Investment Advisers's Q4 2020 filing shows 173 new, 29 increased, 65 reduced and 84 closed positions. Its largest new stake was Slack Technologies, Inc.: 509,889 shares worth $21.5M. The largest sale was Momenta Pharmaceuticals, Inc., an estimated $22.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Gabelli & Co Investment Advisers's largest Q4 2020 buy was Slack Technologies, Inc.: 509,889 shares worth $21.5M.
  • Gabelli & Co Investment Advisers added most to Tiffany & Co. in Q4 2020, an estimated $8.12M increase.
  • Gabelli & Co Investment Advisers's biggest Q4 2020 reduction was Sina Corp, cutting an estimated $2.89M.
  • Gabelli & Co Investment Advisers fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $22.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 35% of its $642M portfolio in Q4 2020.
  • Gabelli & Co Investment Advisers opened 173 new positions and closed 84 in Q4 2020.
  • Gabelli & Co Investment Advisers's portfolio value rose 16% quarter-over-quarter to $642M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2020, filed 5 Feb 2021.